Solos Endoscopy, Inc.'s Breast Endoscopy System Featured in January Issue of Outpatient Surgery Magazine
Posted on: Tuesday, 24 February 2009, 09:41 CST
The MammoView(TM) product line employs advanced microendoscopes and optical technology which can detect precancerous and cancerous cells approximately five years before a mammogram would, as stated in the article. Using the MammoView(TM), doctors can enter the breast through the nipple, navigate through the mammary ducts, where most breast cancers originate and develop, and use irrigation and video technology to observe any abnormalities. The procedure lasts approximately fifteen minuets.
"Solos Endoscopy is pleased to have the MammoView(TM)'s direct advantage to mammography outlined in one of the surgical industries top magazines. We expect that our inclusion will increase the worldwide exposure of our products to potential customers and partners," stated
To view the article in its entirety, please go to www.solosendoscopy.com.
About Outpatient Surgery Magazine: Outpatient Surgery Magazine serves as a meeting place for decision makers in facilities where ambulatory surgery is done. The magazine facilitates the exchange of ideas, advice, experiences and information between surgical facility management team members. It also delivers relevant info and advice from experts, professional advisors, industry, and others: http://www.outpatientsurgery.net/.
About Solos Endoscopy, Inc.: Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
SOURCE Solos Endoscopy, Inc.
Source: PR Newswire
Related Articles
- Solos Endoscopy, Inc.'s Breast Endoscopy System Featured in November Issue of Healthcare Purchasing News Magazine
- Solos Endoscopy, Inc. Receives Purchase Orders from Catholic Health Initiatives for its MammoView(TM) Product Line
- Solos Endoscopy, Inc. Receives Purchase Orders from University of California, San Diego Medical Center for its MammoView(TM) Product Line
- Solos Endoscopy, Inc. Receives Additional Purchase Orders from National Cancer Institute and National Institute of Health for its MammoView(TM) Product Line
- Solos Endoscopy, Inc. Receives Multiple Purchase Orders for its MammoView(TM) Product Line
- Solos Endoscopy, Inc.'s MammoView(TM) Product Line to be Demonstrated at the 95th Annual American College of Surgeons Clinical Congress
- Solos Endoscopy, Inc.'s MammoView(TM) Product Line Receives New Purchase Orders Primarily from Prestigious Teaching Hospitals Across the Country
- Solos Endoscopy, Inc.'s MammoView(TM) Featured in December Issue of Surgical Products Magazine
- Solos Endoscopy, Inc.'s Mammo View(TM) System Introduced in Puerto Rico to Promote Breast Health
 |
 |
User Comments (0)
RSS Feeds